86. Pulmonary arterial hypertension
1,083 clinical trials,   667 drugs   (DrugBank: 122 drugs),   98 drug target genes,   185 drug target pathways

Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01246037
(ClinicalTrials.gov)
February 201118/11/2010Beta-blockers in i-PAHBeta-blocker Therapy in Idiopathic Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionDrug: BisoprololVU University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentActive, not recruiting18 YearsN/ABoth30Phase 1;Phase 2Netherlands
2EUCTR2010-020424-21-NL
(EUCTR)
10/01/201130/08/2010Betablocker Therapy in Pulmonary Arterial HypertensionBetablocker Therapy in Pulmonary Arterial Hypertension Idiopathic pulmonal arterial hypertension
MedDRA version: 12.1;Level: LLT;Classification code 10020787;Term: Hypertension pulmonary
Product Name: Bisoprolol
Product Code: C07AB07
VU medical centerNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands